Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Market Withdrawal of Octagam-Octapharma USA Inc.


December 24, 2007


Octagam [Immune Globulin Intravenous (Human) 5%]
Lot Number: A732B8431
Expiration Date: August 2009


Octapharma USA Inc.
Vienna, Austria


Octapharma USA Inc. has initiated a voluntary withdrawal of one lot of Octagam (Lot A732B8431). They are advising customers not to administer any product from the lot being withdrawn. No other lots of Octagam are affected by this recall. Octapharma is taking this voluntary action based on several reports related to non life-threatening allergic type skin reactions in connection with this lot.

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 06/28/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English